These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 26087120)
1. Chemotherapy at the End of Life: Factors of Prescription. Massard V; Salleron J; Krakowski I; Conroy T; Weber B J Palliat Med; 2015 Aug; 18(8):658-9. PubMed ID: 26087120 [No Abstract] [Full Text] [Related]
2. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer. Kim MK; Lee JL; Hyun MS; Do YR; Song HS; Kim JG; Bae SH; Ryoo HM; Park KU; Lee KH Jpn J Clin Oncol; 2008 Jan; 38(1):64-70. PubMed ID: 18238880 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy at the end of life. Is it compassive?]. Sanz Ortiz J Med Clin (Barc); 2011 Mar; 136(8):343-4. PubMed ID: 21296363 [No Abstract] [Full Text] [Related]
4. Evaluating Chemotherapy at the End of Life. Buiting HM; van den Heuvel MM JAMA Oncol; 2016 Jan; 2(1):143-4. PubMed ID: 26767556 [No Abstract] [Full Text] [Related]
5. Evaluating Chemotherapy at the End of Life. Provenzano AF; Carvajal RD JAMA Oncol; 2016 Jan; 2(1):142-3. PubMed ID: 26767555 [No Abstract] [Full Text] [Related]
6. Evaluating Chemotherapy at the End of Life. Frickhofen N; Maier BO JAMA Oncol; 2016 Jan; 2(1):142. PubMed ID: 26767554 [No Abstract] [Full Text] [Related]
7. Evaluating Chemotherapy at the End of Life--Reply. Prigerson HG; Neugut AI; Maciejewski PK JAMA Oncol; 2016 Jan; 2(1):144. PubMed ID: 26767559 [No Abstract] [Full Text] [Related]
8. Utilization of systemic palliative chemotherapy at the end of life: a local experience. Abdul Monem E; Mehdi I; Al Bahrani BJ; Nada AM; Al Kharusi S J Pak Med Assoc; 2014 Aug; 64(8):863-8. PubMed ID: 25252508 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy Near the End of Life: First--and Third and Fourth (Line)--Do No Harm. Blanke CD; Fromme EK JAMA Oncol; 2015 Sep; 1(6):785-6. PubMed ID: 26203585 [No Abstract] [Full Text] [Related]
10. [Multidisciplinary consultation meetings: decision-making in palliative chemotherapy]. Le Divenah A; David S; Bertrand D; Chatel T; Viallards ML Sante Publique; 2013; 25(2):129-35. PubMed ID: 23964537 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy does not improve quality of life in cancer patients at end of life, US study finds. McCarthy M BMJ; 2015 Jul; 351():h4139. PubMed ID: 26228874 [No Abstract] [Full Text] [Related]
13. Predictors of symptoms and site of death in pediatric palliative patients with cancer at end of life. Schindera C; Tomlinson D; Bartels U; Gillmeister B; Alli A; Sung L Am J Hosp Palliat Care; 2014 Aug; 31(5):548-52. PubMed ID: 23901145 [TBL] [Abstract][Full Text] [Related]
14. [Cost-effectiveness of cancer drug treatments]. Akazawa M Nihon Rinsho; 2015 Feb; 73 Suppl 2():706-12. PubMed ID: 25831852 [No Abstract] [Full Text] [Related]
15. Should chemotherapy be part of end-of-life care? Johns Hopkins Med Lett Health After 50; 2014 Sep; 26(8):6. PubMed ID: 25241413 [No Abstract] [Full Text] [Related]
16. Factors affecting treatment choices in paediatric palliative care: comparing parents and health professionals. Tomlinson D; Bartels U; Hendershot E; Maloney AM; Ethier MC; Sung L Eur J Cancer; 2011 Sep; 47(14):2182-7. PubMed ID: 21669517 [TBL] [Abstract][Full Text] [Related]
17. Effect of integrated palliative care on the quality of end-of-life care: retrospective analysis of 521 cancer patients. Colombet I; Montheil V; Durand JP; Gillaizeau F; Niarra R; Jaeger C; Alexandre J; Goldwasser F; Vinant P BMJ Support Palliat Care; 2012 Sep; 2(3):239-47. PubMed ID: 24654196 [TBL] [Abstract][Full Text] [Related]
19. Less Is More: Polypharmacy at the End of Life. Barak R; Waissengrin B; Wolf I Isr Med Assoc J; 2021 Jul; 23(7):452-453. PubMed ID: 34251131 [No Abstract] [Full Text] [Related]
20. [End of Life medical care: France is not an island in the sea]. Nau JY Rev Med Suisse; 2012 Dec; 8(366):2410-1. PubMed ID: 23346680 [No Abstract] [Full Text] [Related] [Next] [New Search]